Contrasting Neuronetics (NASDAQ:STIM) & ADB International Group (OTCMKTS:EQUR)

ADB International Group (OTCMKTS:EQUR) and Neuronetics (NASDAQ:STIM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.

Analyst Recommendations

This is a summary of recent ratings and target prices for ADB International Group and Neuronetics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADB International Group	0	0	0	0	0.00
Neuronetics	1	0	1	0	2.00

Neuronetics has a consensus target price of $7.00, suggesting a potential upside of 392.96%. Given Neuronetics’ stronger consensus rating and higher probable upside, analysts clearly believe Neuronetics is more favorable than ADB International Group.

Valuation and Earnings

This table compares ADB International Group and Neuronetics”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADB International Group	N/A	N/A	N/A	N/A	N/A
Neuronetics	$74.89 million	1.30	-$43.71 million	($0.82)	-1.73

ADB International Group has higher earnings, but lower revenue than Neuronetics.

Profitability

This table compares ADB International Group and Neuronetics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ADB International Group	N/A	N/A	N/A
Neuronetics	-33.88%	-131.15%	-31.26%

Insider & Institutional Ownership

53.6% of Neuronetics shares are held by institutional investors. 79.6% of ADB International Group shares are held by insiders. Comparatively, 8.7% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Neuronetics beats ADB International Group on 5 of the 9 factors compared between the two stocks.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

About Neuronetics

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.